DE3576957D1 - Carbapenemverbindungen, deren herstellung und verwendung. - Google Patents

Carbapenemverbindungen, deren herstellung und verwendung.

Info

Publication number
DE3576957D1
DE3576957D1 DE8585309537T DE3576957T DE3576957D1 DE 3576957 D1 DE3576957 D1 DE 3576957D1 DE 8585309537 T DE8585309537 T DE 8585309537T DE 3576957 T DE3576957 T DE 3576957T DE 3576957 D1 DE3576957 D1 DE 3576957D1
Authority
DE
Germany
Prior art keywords
sup
compounds
carbapene
production
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585309537T
Other languages
English (en)
Inventor
Yukio Chemical Resear Sugimura
Toshihiko Chemical R Hashimoto
Teruo Chemical Research Tanaka
Shinichi Research Ins Sugawara
Kimio Chemical Research L Iino
Tomoyuki Chemical Rese Shibata
Tetsuo Research Plann Miyadera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE3576957D1 publication Critical patent/DE3576957D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)
DE8585309537T 1984-12-25 1985-12-30 Carbapenemverbindungen, deren herstellung und verwendung. Expired - Fee Related DE3576957D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28170084 1984-12-25

Publications (1)

Publication Number Publication Date
DE3576957D1 true DE3576957D1 (de) 1990-05-10

Family

ID=17642759

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585309537T Expired - Fee Related DE3576957D1 (de) 1984-12-25 1985-12-30 Carbapenemverbindungen, deren herstellung und verwendung.

Country Status (18)

Country Link
US (1) US4740507A (de)
EP (1) EP0186525B1 (de)
JP (1) JPS61275279A (de)
KR (1) KR930005332B1 (de)
CN (1) CN1014246B (de)
AT (1) ATE51624T1 (de)
AU (1) AU575232B2 (de)
CA (1) CA1254562A (de)
DE (1) DE3576957D1 (de)
DK (1) DK169384B1 (de)
ES (2) ES8706148A1 (de)
FI (1) FI81576C (de)
HU (1) HU196071B (de)
IE (1) IE58823B1 (de)
NO (1) NO163957C (de)
NZ (1) NZ214676A (de)
PH (1) PH25391A (de)
ZA (1) ZA859797B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd 1―置換カルバペネム―3―カルボン酸誘導体
JPS6426580A (en) * 1987-07-21 1989-01-27 Sankyo Co Production of carbapenem derivative
US5102877A (en) * 1989-04-28 1992-04-07 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
US5286721A (en) * 1990-10-15 1994-02-15 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
TW209220B (de) * 1991-11-27 1993-07-11 Manyu Seiyaku Kk
GB9202298D0 (en) 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
GB9210096D0 (en) * 1992-05-11 1992-06-24 Fujisawa Pharmaceutical Co 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives and their preparation
JP2696807B2 (ja) * 1992-08-06 1998-01-14 田辺製薬株式会社 カルバペネム誘導体の製法
HUP0000952A3 (en) * 1997-02-07 2000-12-28 Kyoto Pharma Ind Carbapenem compounds, process for their preparation and pharmaceutical compositions containing them
AU760386B2 (en) 1998-05-01 2003-05-15 Kyoto Pharmaceutical Industries, Ltd. Carbapenem derivatives, utilization thereof and intermediate compounds of the same
HUP0400444A3 (en) * 2001-05-21 2007-02-28 Kyoto Pharmaceutical Ind Carbapenem compound, pharmaceutical compositions containing them and their use
GB0400382D0 (en) * 2004-01-09 2004-02-11 Glaxo Group Ltd Novel processes
US7932381B2 (en) * 2005-02-15 2011-04-26 Shionogi & Co., Ltd. Process for producing carbapenem derivative and intermediate crystal therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383946A (en) * 1980-03-27 1983-05-17 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
JPS5913757A (ja) * 1982-07-14 1984-01-24 Sankyo Co Ltd 3−メルカプトピロリジン誘導体及びその製法
JPS5916892A (ja) * 1982-07-19 1984-01-28 Sankyo Co Ltd カルバペネム−3−カルボン酸誘導体およびその製法
JPS59205379A (ja) * 1983-05-09 1984-11-20 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物及びその製造法
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF

Also Published As

Publication number Publication date
HU196071B (en) 1988-09-28
CA1254562A (en) 1989-05-23
ES557035A0 (es) 1987-08-01
ZA859797B (en) 1986-09-24
IE853300L (en) 1986-06-25
DK169384B1 (da) 1994-10-17
CN1014246B (zh) 1991-10-09
NO163957B (no) 1990-05-07
CN85109699A (zh) 1986-08-13
ATE51624T1 (de) 1990-04-15
NO855241L (no) 1986-06-26
KR930005332B1 (ko) 1993-06-17
NZ214676A (en) 1988-06-30
DK604485D0 (da) 1985-12-23
FI81576C (fi) 1990-11-12
KR860004892A (ko) 1986-07-14
EP0186525B1 (de) 1990-04-04
NO163957C (no) 1990-08-15
JPS61275279A (ja) 1986-12-05
DK604485A (da) 1986-06-26
FI855128A (fi) 1986-06-26
PH25391A (en) 1991-06-03
ES550403A0 (es) 1987-06-01
AU575232B2 (en) 1988-07-21
AU5169985A (en) 1986-07-03
HUT39182A (en) 1986-08-28
US4740507A (en) 1988-04-26
FI81576B (fi) 1990-07-31
FI855128A0 (fi) 1985-12-20
ES8706148A1 (es) 1987-06-01
ES8707535A1 (es) 1987-08-01
EP0186525A1 (de) 1986-07-02
IE58823B1 (en) 1993-11-17

Similar Documents

Publication Publication Date Title
ES8700672A1 (es) Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos.
DE3576957D1 (de) Carbapenemverbindungen, deren herstellung und verwendung.
DE3581465D1 (de) Pyridazinonderivate, deren herstellung und verwendung.
ES8703150A1 (es) Metodo de preparar derivados de b-carbolin-3-oxadiazolilo
ES557061A0 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina
LU91031I2 (en) Zaxem
ES8609272A1 (es) Un procedimiento para preparar derivados de hidantoina
ES8703870A1 (es) Procedimiento para preparar compuestos de 5-alquil-1-fenil-2-piperazinoalquilpirazolin-3-ona.
IL74401A0 (en) Thiophenylureas,their production and use
AU2610684A (en) 6-hydroxyalkyl-penem derivatives
ES8607963A1 (es) "un procedimiento para la preparacion de derivados de imi- dazol triciclicos"
ES8406507A1 (es) Procedimiento para la preparacion de hexanorbrassinolid-22-eteres
ATE23158T1 (de) Hexahydrodioxopyrimidine, ihre herstellung und verwendung.
DE3564937D1 (en) Novel substituted phenyl ethers, process for their preparation, and their use in the preparation of substituted phenols
ES8801648A1 (es) Procedimiento de preparar derivados bisimidazolinoamino, utiles como compuestos antialergicos.
ATE15184T1 (de) Fluorphenoxybenzylester, ihre herstellung und ihre verwendung als schaedlingsbekaempfungsmittel.
TW338707B (en) Pyridylacetic acid derivative with its manufacturing method and the intermediate as well as the use
CA1268179A (en) .BETA.-CARBOLIN-3-OXADIAZOLYLIC DERIVATIVES; METHOD OF PREPARATION AND USE

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee